BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

XOMA (US) LLC 

2910 Seventh Street

Berkeley  California  94710  U.S.A.
Phone: 510-204-7200 or 800-BIO-XOMA
Fax: 510-644-0539


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
XOMA (US) LLC (XOMA) Highlights Recent Achievements And Reports Financial Results For Second Quarter 2014 8/8/2014 7:51:11 AM
XOMA (US) LLC (XOMA) To Present At Two Upcoming Investor Conferences 8/6/2014 4:32:52 PM
XOMA (US) LLC (XOMA) To Announce Second Quarter 2014 Financial Results And Host Webcast On August 7 7/30/2014 4:05:03 PM
XOMA (US) LLC (XOMA) Call Today At 4:30pm ET/1:30pm PT To Confirm Communication Plan For EYEGUARD®-B Clinical Program 7/1/2014 10:24:13 AM
XOMA (US) LLC (XOMA) To Present At The Jefferies and Co. Global Healthcare Conference 5/29/2014 9:30:36 AM
XOMA (US) LLC (XOMA) Reports First Quarter 2014 Operational Highlights And Financial Results 5/8/2014 9:26:52 AM
XOMA (US) LLC (XOMA) To Announce First Quarter 2014 Financial Results And Host Webcast On May 7 4/30/2014 5:17:44 PM
XOMA (US) LLC (XOMA) Finalizes Plans For Gevokizumab Phase 3 Clinical Program In Pyoderma Gangrenosum 4/28/2014 9:04:04 AM
XOMA (US) LLC (XOMA) Reports 2013 Operational Highlights And Fourth Quarter And Full-Year 2013 Financial Results 3/5/2014 9:19:15 AM
XOMA (US) LLC (XOMA) Receives Orphan Drug Designation From U.S. FDA for Pyoderma Gangrenosum 2/25/2014 9:17:52 AM
12345678910...